Compare up to 40 stocks
Compared Stocks: 1 / 40
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 CHSYF | General | $1.27 | 0.00 | $3.21B | 13.82 | 3.39% | Strong Buy |
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CHSYF | China Medical System Holdings | 1.27 | -0.01 | -1.07% |
| Name | Price | % Change | |
|---|---|---|---|
| CHSYF | $1.27 | -1.07% |
The latest update is out from China Medical System Holdings ( ($HK:0867) ). China Medical System Holdings, through its commercialization subsidiary Rxilient Medical, received Singapore approval for Lumirix (ruxolitinib phosphate
China Medical System Holdings ( ($HK:0867) ) has provided an update. China Medical System Holdings reported no changes in its authorized share capital or ordinary-share count for October 2026, leaving
An update from China Medical System Holdings ( ($HK:0867) ) is now available. China Medical System Holdings has announced an administrative change to its Singapore share transfer arrangements, effective 1
China Medical System Holdings ( ($HK:0867) ) has shared an announcement. China Medical System Holdings Limited has received approval from China’s National Medical Products Administration to conduct clinical trials of
An update from China Medical System Holdings ( ($HK:0867) ) is now available. China Medical System Holdings said Dermavon has secured Chinese regulatory approval for a new indication of its
An announcement from China Medical System Holdings ( ($HK:0867) ) is now available. China Medical System Holdings Limited has reminded shareholders that it has adopted electronic dissemination of its corporate
China Medical System Holdings ( ($HK:0867) ) has provided an announcement. China Medical System Holdings has formalised a shift to electronic dissemination of its corporate communications, making documents such as
An update from China Medical System Holdings ( ($HK:0867) ) is now available. China Medical System Holdings reported that its authorised share capital remained unchanged in August 2026, with 20
An update from China Medical System Holdings ( ($HK:0867) ) is now available. China Medical System Holdings Limited has revised its interim dividend for the six months ended 30 June
China Medical System Holdings ( ($HK:0867) ) has provided an announcement. China Medical System Holdings reported interim results for the first half of 2026, with turnover rising 12.5% to RMB4.5
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| CHSYF | Mar 16, 2027TBA | $3.21B | $0.06 | $738.01M | -2.50 | 13.82 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
